Anti Age Magazine
  • Home
  • About us
  • Magazine
    • Europe
    • International
    • Special men
  • Congress
    • Important Events
    • Informations
  • Estetic for Men
  • Subscribe now!
  • Aesthetic Medicine
  • Cosmeceutics
  • Health & Nutrition
  • Medical Spa
  • About us
    • Editorial Board
    • Anti Age Magazine
    • Our experts
    • Partners
    • Contact us
    • Subscribe now
Anti Age Magazine
Anti Age Magazine
  • Home
  • About us
  • Magazine
    • Europe
    • International
    • Special men
  • Congress
    • Important Events
    • Informations
  • Estetic for Men
  • Subscribe now!
Français
  • Aesthetic Medicine
  • Injectables

Interview: Gerry Muhle, head of global product Galderma

  • 25th March 2024
  • Thierry PIOLATTO

In this interview, we caught up with Gerry Muhle, Head of Global Product Strategy at Galderma, and discussed current and future aesthetics trends, as well as some of the company’s latest and upcoming product innovations. 

ANTI-AGE Magazine: Current trends show growing interest among millennials in injectables. Is this a major target for Galderma?

Gerry muhle: Aesthetics is becoming more and more part of our beauty, health and wellness routines, and that is especially true for younger generations – those under 40, including millennials and Gen Z. Social media influence, new aesthetic technologies, expertise and accessibility are all factors that intersect, and create new possibilities and demands from consumers, including millennials. As a result, we see the world of aesthetic increasingly colliding with mainstream beauty and fashion, and we need to adapt and find new ways to answer the specific needs of these generations. 

AAM: The aesthetic trends that you identified in your NEXT by Galderma report show that patients’ motivations are very diverse. How can we meet them?

G.M.: Catering to these motivations and needs requires us to first anticipate and understand them, which is exactly what we have done with NEXT by Galderma, by identifying the emerging trends and aesthetic needs of tomorrow. It also means having the right products to answer them, something that Galderma is uniquely positioned to do, with the broadest Injectable Aesthetics portfolio on the market. Like many other areas of our lives already, I expect that aesthetics will see an increasing number of new, bespoke offerings in the future, using for instance integrated product approaches from across different parts of our portfolio to allow for truly individualised results. This also requires new capabilities from healthcare professionals, something that Galderma is actively working on through its education and training platforms. 

AAM: Can we reconcile a “beauty” discourse with a scientific approach?

G.M.: Undoubtedly yes. Science is a critical force for us at Galderma, that has been driving the products that we develop across therapeutic dermatology, injectable aesthetics and dermatological skincare. Every Galderma product available to patients and consumers is backed by robust science, which is why we have so many long-standing brands in our portfolio that have been serving customers for decades, along with new innovations building on the latest research and technologies. 

AAM: Sculptra® is celebrating its 25th anniversary and we are seeing a boom in biostimulators. How do you explain this enthusiasm?

G.M.: More consumers are now becoming aware of the role that collagen plays in the aging process and are looking for solutions to address collagen loss. Sculptra® is a great option for these consumers, because of its unique ability to stimulate the body’s own production of collagen, therefore working “with the body” to address the root cause of skin aging, and by providing unmatched, progressive, natural-looking results that last more than 2 years. This enthusiasm for biostimulators reflects three of the trends that we have identified in NEXT by Galderma: addressing aging before it is apparent (‘Proactive Beauty’), the priority given to products with minimal environmental impact, that align with consumers’ ethical values and provide natural-looking results (‘Mindful Aesthetics’) and the desire to use aesthetics to look and feel good at any age, rather than solely seeking to reverse or eradicate signs of aging (‘Cancelling Age’). 

AAM: What is the indication of the new Restylane® Shaype™ and what are its specific features?

G.M.: Restylane® SHAYPE™ is the latest addition to our Restylane portfolio, the world’s most diverse range of hyaluronic acid (HA) injectables. Powered by new NASHA HD™ technology from Galderma, Restylane SHAYPE has the highest G prime, which makes it the firmest HA gel available on the market while remaining the closest to skin’s own HA. As such, thanks to its bone mimicking effect, it allows aesthetic injectors to shape, project and elongate the chin and can be readily reversed. For decades, there has been heavy reliance on implants to create structure in the lower face. With Restylane SHAYPE patients now have a new, innovative, non-surgical option for chin remodelling.

AAM: You are working on the arrival of a new botulinum toxin in 2025. Does it have distinct characteristics from Azzalure? 

G.M.: With our investigational RelabotulinumtoxinA, we are aiming to bring a truly novel and unique solution to the market, for the treatment of lateral canthal and glabellar lines. First, thanks to its proprietary, unique state-of-the-art manufacturing process, it is a highly-active and complex-free molecule which has demonstrated compelling results in our READY clinical trials, with high patient satisfaction, rapid onset of action from day 1, long duration of 6 months and natural-looking results. Second, it is designed as a liquid. This avoids the traditional requirement to reconstitute from powder, eliminating the risk of variability and errors, which is expected to improve the consistency of results for patients and increase convenience for injectors. This is truly exciting, and we are very much looking forward to this addition to our neuromodulator portfolio. l

More info on Next by Galderma: galderma.com/next-galderma

Total
0
Shares
Share 0
Share 0
Share 0
Thierry PIOLATTO

Previous Article
  • Aesthetic Medicine

Going beyond trends: showcasing true originality, through individuality, innovation and integrity

  • 25th March 2024
  • Thierry PIOLATTO
View Post
Next Article
  • Cosmeceutics

REVITACARE: Over 20 years dedicated to skin quality

  • 25th March 2024
  • Thierry PIOLATTO
View Post
You May Also Like
View Post
  • Aesthetic Medicine
  • Cellulite

 CELLUTION BY DELEO

  • Thierry PIOLATTO
  • 14th May 2025
View Post
  • Aesthetic Medicine
  • Informations

Imcas World Congress 2025

  • Thierry PIOLATTO
  • 25th March 2025
View Post
  • Aesthetic Medicine
  • Radiofrequency

ATTIVA internal radiofrequency

  • Thierry PIOLATTO
  • 25th March 2025
View Post
  • Aesthetic Medicine
  • Lasers

Choosing a new Laser for our Aesthetic Surgery and Medicine Centre

  • Thierry PIOLATTO
  • 25th March 2025
View Post
  • Aesthetic Medicine
  • Photobiostimulation

icoone®: Micro actions, macro changes

  • Thierry PIOLATTO
  • 25th March 2025
View Post
  • Aesthetic Medicine
  • Lifting

How can we optimise the results of a face lift and make it last? 

  • Thierry PIOLATTO
  • 25th March 2025
View Post
  • Aesthetic Medicine
  • Radiofrequency

Aesthetic Medicine: An holistic approach beyond appearance

  • Thierry PIOLATTO
  • 25th March 2025
View Post
  • Aesthetic Medicine
  • Filler
  • Injectables

ALBUMIN-PRF

  • Thierry PIOLATTO
  • 25th March 2025
Latest news
    • Congress
    • Informations
    Dubai Derma Concludes with Deals Exceeding AED 2.5 billion
    • Aesthetic Medicine
    • Cellulite
     CELLUTION BY DELEO
    • Anti Age Magazine
    Anti Age Magazine #58
    • Medical Spa
    Jonzac, Rochefort and Saujon, Thermalism in Charentes, France
    • Medical Spa
    Côté Thalasso, Banyuls sur mer, France
FIND AESTHETIC MEDICINE EXPERTS ON ZESTETIK.FR
Translate
Tags
aesthetics Allergan anti-age anti-ageing anti-ageing cream anti-aging cream anti-aging skincare Anti-aging sun protection Anti ageing medicine Anti Ageing practician anti age mag anti age magazine botox botulinum toxin cosmetics cryolipolysis dermatologist filler fillers Filorga Galderma HA HA dermal fillers HA fillers hotel hyaluronic acid hydropeptide injectable Juvederm Volift Retouch luxe luxury maldives massage mesoestetic mesotherapy nacriderm skincare skingold SoftFil spa Teoxane thalasso weight loss wellbeing youth
Contact us
redaction@aagedition.com

AAG, Immeuble D
66 avenue des Champs Elysées
75008 Paris, France.

aagedition.com

Do you need to advertise?

  • About us
  • Our experts
  • Partners
  • Do you need to advertise?
Follow us

Input your search keywords and press Enter.

We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in .

Anti Age Magazine
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.

3rd Party Cookies

This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.

Keeping this cookie enabled helps us to improve our website.

Please enable Strictly Necessary Cookies first so that we can save your preferences!